Security key
877619106
Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)
CUSIP: 877619106
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 130,129,882
- Total 13F value
- $230,288,972
- Share change
- -1,105,945
- Put/Call ratio
- 30%
- SEC-reported price per share
- $1.77
- Number of holders
- 85
- Value change
- -$12,329,934
- Number of buys
- 56
- Number of sells
- 18
- Shares outstanding
- 285,714,286
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2023
Institutions
85
Top holders
10
TSHA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Taysha Gene Therapies, Inc. SEC filings
Taysha Gene Therapies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 877619106
Recent filing periods:
Ownership snapshot
Top reported holders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 8.6%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 8.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
FMR LLC
8.6%
RA CAPITAL MANAGEMENT, L.P.
6.5%
RTW INVESTMENTS, LP
5.9%
Venrock Adviser, LLC
5.1%
TCG Crossover Management, LLC
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
8.6%
|
$77,507,851
24,527,801 shares
|
— | 30 Sep 2023 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
6.5%
|
$58,373,109
18,472,503 shares
|
— | 30 Sep 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
5.9%
|
$53,382,465
16,893,185 shares
|
— | 30 Sep 2023 |
| Venrock Adviser, LLC |
13F
Company
|
5.1%
|
$45,644,443
14,444,444 shares
|
— | 30 Sep 2023 |
| TCG Crossover Management, LLC |
13F
Company
|
3.9%
|
$35,111,111
11,111,111 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1.9%
|
$16,836,050
5,327,864 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
85
Shares
130,129,882
Rows available
85
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
59
Q4 2023 holders
85
Holder diff
26
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend